|
|
Zila News (NASDAQ:ZILA)
| Latest Zila News Headlines | | Date | Time | Source | | | 08/28/2008 | 10:20AM | PRNUS | BeaconEquity.com Issues Technical Trade Alerts on Healthcare Stocks: ZILA, VITA, EYE, JNJ, NVS, MRK
DALLAS, Aug. 28 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today.
Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m
Today's Trade Alerts include: Zila Inc. (NASDAQ:ZILA), Orthovita Inc. (NASDAQ:VITA), Advanced... More...>> |
| 09/04/2007 | 7:35AM | PRNUS | Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
- ViziLite Plus with TBlue630 -
PHOENIX, Sept. 4 /PRNewswire-FirstCall/ -- Zila, Inc.'s (NASDAQ:ZILA) ViziLite(R) Plus with Tblue630(TM) screening system for early detection of abnormalities which can lead to oral cancer, has been selected to identify pre-cancerous lesions in a Phase II study of Cetuximab (ERBITUX(R... More...>> |
| 08/28/2007 | 9:00AM | PRNUS | Zila To Present at Roth 2007 New York Conference
PHOENIX, Aug. 28 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA) today announced that Frank J. Bellizzi, DMD, president of Zila Pharmaceuticals, will present a company overview at the Roth 2007 New York Conference on Wednesday, September 5, 2007 at 4:30 p.m. ET at The Westin New York Hotel at Times Square.
Interested... More...>> |
| 08/28/2007 | 9:00AM | PRNUS | Zila To Present at Roth 2007 New York Conference
PHOENIX, Aug. 28 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA) today announced that Frank J. Bellizzi, DMD, president of Zila Pharmaceuticals, will present a company overview at the Roth 2007 New York Conference on Wednesday, September 5, 2007 at 4:30 p.m. ET at The Westin New York Hotel at Times Square.
Interested... More...>> |
| 08/16/2007 | 4:03PM | PRNUS | Zila Names David R. Bethune Executive Chairman; Adds J. Steven Garrett to Board of Directors
PHOENIX, Aug. 16 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA) today announced that its board of directors has named David R. Bethune as executive chairman. Bethune has been a member of the board since 2005 and was appointed chairman on May 21, 2007.
The board also elected J. Steven Garrett, MS, DDS, FACD, as... More...>> |
| 08/14/2007 | 10:30AM | PRNUS | Zila Takes Steps to Restructure Its Business
- Company Poised For Growth -
PHOENIX, Aug. 14 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA), announced it has taken significant steps to restructure its business through the amendment of its $12 million convertible note, an evaluation of its OraTest program and a major cost reduction program.
Debt Covenant Amendments
Zila... More...>> |
| 08/01/2007 | 1:00PM | PRNUS | Zila Announces CFO Management Change
PHOENIX, Aug. 1 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA), announced today that Lawrence A. Gyenes has resigned as Chief Financial Officer in order to pursue other interests. Diane E. Klein, Vice President and Treasurer, was promoted to Vice President of Finance and has assumed the duties of the principal financial... More...>> |
| 07/10/2007 | 4:02PM | PRNUS | Zila Executive and Board Chairman Acquire Stock
PHOENIX, July 10 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA), announced that the President of its Pharmaceutical division, Frank Bellizzi, acquired 50,000 shares of Zila common stock on Friday, July 6. Additionally, Dr. Bellizzi committed 14% of his salary for the balance of the calendar year to the acquisition... More...>> |
| 03/28/2007 | 7:00AM | PRNUS | Zila Pharmaceuticals Says Guardian Life Insurance Company of America Will Cover ViziLite(R) Plus With TBlue630 in Dental PPO Net
PHOENIX, March 28 /PRNewswire/ -- Zila Pharmaceuticals, Inc., a division of Zila, Inc. (NASDAQ:ZILA) and marketer of the ViziLite(R) Plus with TBlue630 system for the early detection of oral abnormalities that could lead to cancer, announced that The Guardian Life Insurance Company of America (Guardian) will offer coverage... More...>> |
| 02/13/2007 | 1:38PM | PRNUS | Oral Cancer Cases to Increase 11 Percent This Year
PHOENIX, Feb. 13 /PRNewswire-FirstCall/ -- Zila, Inc. (NASDAQ:ZILA) noted with dismay that while the American Cancer Society (ACS) celebrated new data with a headline "Cancer Deaths Down for Second Year", the same data showed a marked increase in the number of expected new cases and deaths due to oral cancer.
"The... More...>> |
| 08/14/2006 | 7:30AM | PRNUS | NBTY to Acquire Ester-C(R): A Well Known Branded and Patented Highly Effective Form of Vitamin C
BOHEMIA, N.Y., Aug. 14 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE:NTY) (http://www.nbty.com/), a leading global manufacturer and marketer of nutritional supplements, today announced it has entered into a contract to acquire Zila Nutraceuticals, Inc., manufacturer and marketer of the Ester-C(R) nutritional supplement... More...>> |
| 04/04/2006 | 8:00AM | PRNUS | Black Diamond Commercial Finance Closes $40 Million Financing with Zila, Inc.
STAMFORD, Conn., April 4 /PRNewswire/ -- Black Diamond Commercial Finance, L.L.C., a privately held, independent commercial finance company, has provided a $40 million senior secured credit facility for Zila, Inc. (NASDAQ:ZILA), a leading innovator in preventive healthcare technologies and products that emphasize enhanced... More...>> |
| 10/29/2004 | 1:29PM | PRNUS | Flu Vaccine Shortage May Force Americans to Resort to Other Flu Prevention Methods
Flu Vaccine Shortage May Force Americans to Resort to Other Flu
Prevention Methods
Monitor the Severity of Your Flu Risk and Learn About Zila Nutraceuticals'
Ester-C(R) Immune System Health Benefits Online
PRESCOTT, Ariz., Oct. 29 /PRNewswire/ -- With the increased threat of illness
this flu season due to the vaccine... More...>> |
|
|
|